Strengthen Your Bones Safely and Without Medication

Introducing Osteoboost, the first vibration belt specifically designed to reduce the decline in bone strength and bone density in postmenopausal women with osteopenia.

There is an Escalating Rate of Osteoporosis Despite 25 Years of Drug Treatment Options

1 in 2 women and 1 in 4 men over 50 will suffer a bone density related fracture



“Fearing Drugs’ Rare Side Effects, Millions Take their Chances With Osteoporosis”

— New York Times

Introducing Osteoboost

OsteoBoost is the first vibration belt specifically designed to reduce the loss of bone strength and bone density in postmenopausal women.

SIMPLE YET EFFECTIVE

The Osteoboost Vibration Belt applies gentle mechanical stimulation to the hips and spine to improve bone strength.

BASED ON NASA RESEARCH

Leveraging 15 years of published research (starting with NASA) proving that vibration at a precise amplitude and frequency stimulates bones, Osteoboost delivers the optimal therapeutic dose directly to the most vulnerable anatomy, the hips and lumbar spine.

CLINICAL RESEARCH

Osteoboost has been studied in multiple National Institutes of Health (NIH) funded clinical trials, based on a successful pilot study that showed a significant reduction in bone turnover markers after just one treatment.

EASY AND CONVENIENT

Comfortable and as easy as putting on a belt, one 30-minute treatment per day while doing chores or walking the dog makes Osteoboost easy to fit into any lifestyle.

Bone Mineral Density in Women Over Time

There are over 1 million hip and spine fractures each year due to osteopenia and osteoporosis

The Osteoboost Difference

REDUCTION IN BONE LOSS ACTIVITY

In a recently published study, Osteoboost induced an acute reduction in bone loss activity as measured by the biomarker NTx (mean: 14%, p<0.001).

REDUCED THE LOSS OF BONE STRENGTH

Pivotal trial results showed a dramatic reduction in the loss of vertebral bone strength and density as measured by CT Scan

GREAT EARLY INTERVENTION

Osteoboost can be used safely during osteopenia whereas medications are used typically for osteoporosis.

HIGH COMPLIANCE

Compliance is high at over 80%.

Treatment Compliance Rate

Current medication treatments are used by less than 10% of patients for whom they are indicated and have a high rate of treatment discontinuation.

Osteoboost is easy and convenient to use, with high compliance and satisfaction ratings. 

Compliance

How It Works

The Osteoboost Vibration Belt is simple to use, and includes an auto-shutoff feature that ends treatment after 30 minutes. Use daily or at least 5 days a week for full treatment effect.

Easy to attach velcro secures it around the waist.

STEP 1

Simply press power and it begins the gentle vibration treatment.

STEP 2

Once treatment beings, you can go about your business.

STEP 3

Chan et al., 2013. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep 11: p. 36-44. 

NASA Research Leads to Vibration Belt Technology

Developed from NASA proven technology, OsteoBoost takes vibration therapy to another level by delivering precise mechanical stimulation targeted to the areas of the body that need it most, the hips and spine.

Our Team

Laura Yecies

Chief Executive Officer, President

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo. MBA from Harvard, MSFS Georgetown School of Foreign Service, AB Dartmouth College.

Pamela Peeke, MD

Chief Medical Officer

Expert in women’s health, menopause, and longevity, member of the National Menopause Foundation Medical Advisory Board and a Trustee on the American College of Sports Medicine Board.

Derek Hillstrom

VP Engineering

20 years of medical device development and manufacturing at St Jude Medical, Autonomic Technologies and Niveus Medical

Meghan Griffin

Clinical Operations

Experienced running clinical trials for several novel medical devices.

Dave McGurl

Regulatory

Director of Regulatory Affairs at MCRA and expert in orthopedics and medical devices. worked for 7 years at the FDA in the premarket orthopedic devices as acting branch chief and senior premarket lead reviewer. 

Gabriel Griego

Marketing

Seasoned sales & marketing leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.

Board Members

Laura Yecies

CEO, MBA, MSFS

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.  MBA from Harvard Business School, MSFS Georgetown, AB Dartmouth College.

Shane Mangrum

Founder, MD

Physical Medicine and Rehabilitation (PM&R) physician at Polaris Spine in Atlanta, GA; Specialist in non-operative spine and musculoskeletal care. Dr. Mangrum is also a co-inventor of the OsteoBoost technology

Eric Meyer

MBA

Expert in launching novel consumer medical, health and wellness products. Led Sonicare™’s commercial efforts from launch to  #1 dollar share power toothbrush brand in the U.S., and to Inc. Magazine’s #1 fastest growing privately-held company. Prior to Sonicare, served in senior marketing and sales positions at LifeScan where he launched the One Touch™ blood glucose monitor. MBS from Stanford University

Jeani Delagardelle

MBA

Experienced venture investor and business leader who specializes in founding and developing healthcare technology companies, across all stages of development and therapeutic areas, for either acquisition or IPO. She is a Co-founder and former Managing Director of New Leaf Venture Partners, a leading life science venture capital firm, spun out of the Sprout Group. MBA from University of California Irvine

John Osborne

BS

Managing Partner, Good Growth Capital.  Over a decade working various roles in the finance industry including in commercial banking, private banking and angel investing. Co-founded and Director of The Harbor Entrepreneur Center, Charleston. Executive Administrator of Charleston Angel Partners. B.S. in Finance from Charleston Southern University

Sam Goldberger

MD, MBA

Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon. . MD from Albert Einstein College of Medicine, and MBA from MIT Sloan. Led a successful ophthalmology practice roll up and founded a healthcare and life-science investing firm.

Marcie Hamilton

BS

Medical device operations and program management leader, co-founded Potrero Medical and incubated Bone Health Technologies. Managed VIvaRay Inc. to successful acquisition by Varian Medical Systems.

Advisors & Investigators

Harold Rosen

MD

Professor of Endocrinology at Harvard Medical School, Director Osteoporosis Prevention and Treatment Center at Beth Israel Deaconess Medical Center, leading expert in bone densitometry, biochemical markers of bone turnover and metabolic bone disease.

David B. Karpf

MD

Professor of Endocrinology at Stanford University School of Medicine, Director Stanford Osteoporosis and Metabolic Bone Disease Clinic, leading researcher on Osteoporosis medications (Fosomax trial) and board member of American Bone Health

Dolores Shoback

MD

Professor of Medicine, UCSF, Staff Physician San Francisco, VA, and board member of American Bone Health. Dr. Shoback is a recognized authority in metabolic bone disease, parathyroid disorders and osteoporosis. She also co-directs UCSF’s physician training program in diabetes, endocrinology and metabolism.

Anne Schafer

MD

Chief of Endocrinology and Metabolism San Francisco, VA, Associate Professor of Medicine and Epidemiology & Biostatistics at UCSF.  Dr. Schafer is an expert on optimizing osteoporosis treatment and the relationships between bone, fat, and glucose metabolism.

Laura Bilek

PhD, PT

Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Expert in clinical research for the treatment of low bone mass.

Tony Keaveny

PhD

Professor of Mechanical Engineering and Bioengineering, UC Berkeley, director of the Berkeley Orthopaedic Biomechanics Lab; Expert in bone mechanics and inventor of VirtuOst.

Investors

Berkeley Angel Network

52 million Americans have Osteopenia

Now they have a good option to reduce their loss of bone strength
that is easy to use and fits into their daily lifestyle

Contact us

At this time OsteoBoost is not available for sale. Please fill out the form if you would like to be notified when the product is available.

* indicates required